Latest Breaking News On - Nerve society annual - Page 1 : comparemela.com

Regulatory progress for govorestat for the treatment of Classic Galactosemia, with potential NDA submission based on discussions with the FDA as well as EMA Marketing Authorization Application. -Today at 07:04 am- MarketScreener

United statesAdvanz pharmaShoshana shendelmanMaeve conneightonPeripheral nerve society annual meetingTherapeutics incMeeting of the american diabetes associationDrug administrationMeeting of the peripheral nerve societyEuropean medicines agencyExchange commissionClassic galactosemiaAuthorization applicationSorbitol dehydrogenaseDiabetic cardiomyopathyChief executive officer